OBJECTIVES: Individuals with HIV infection are at an increased risk for a number of infectious diseases, some of which are preventable by vaccination. Unfortunately, little is known about the attitudes of this population group to vaccination, therefore, we decided to find out vaccination coverage against 5 infections among newly diagnosed HIV-infected patients in the Czech Republic. METHODS: This cross-sectional study was conducted on newly diagnosed patients who started their follow-up care at the HIV Clinic of Na Bulovce Hospital during the two following years. Vaccination history data and results of serological tests were collected from all participants. RESULTS: Enrolled were 269 HIV-positive subjects (94.1% males) with a mean age of 34.4 years, 64 subjects (23.8%) had tertiary education, 229 (85.1%) were men having sex with men, 32 (11.9%) were heterosexual, and 8 (3.0%) were injection drug users. The mean CD4+ T-lymphocyte count was 556.2/µL, with 149 persons (55.4%) who had a CD4+ T-lymphocyte count > 500/µL, and 68 (25.3%) individuals were late presenters with CD4+ T-lymphocyte count < 350/µL. A vaccination against tetanus was reported by 262 subjects (97.4%), against influenza by 18 subjects (6.7%), against tick-borne encephalitis by 18 subjects (6.7%), against viral hepatitis A by 78 persons (29.0%), and against hepatitis B by 104 subjects (38.7%). For influenza, tick-borne encephalitis and hepatitis A, a significant positive impact of tertiary education was found (p-values < 0.001-0.044). Vaccination coverage against both types of hepatitis was significantly lower in late presenters (p = 0.044 and p = 0.004, respectively). CONCLUSIONS: Vaccination rates found in our cohort were except tetanus and hepatitis B in young people low, especially for influenza and tick-borne encephalitis. Higher level of education and less advanced HIV infection were associated with higher vaccination rates. To improve this unsatisfactory situation, more attention should be paid to vaccination.

• Klíčová slova
• HIV, hepatitis, influenza, tetanus, tick-borne encephalitis, vaccination coverage,
• MeSH
• dospělí MeSH
• HIV infekce * diagnóza   MeSH
• lidé MeSH
• mladiství MeSH
• počet CD4 lymfocytů metody   MeSH
• pokrytí očkováním * MeSH
• průřezové studie MeSH
• Check Tag
• dospělí MeSH
• lidé MeSH
• mladiství MeSH
• mužské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Česká republika MeSH

Seasonal influenza can have serious morbid consequences and can even result in death, particularly in at-risk populations, including healthcare professionals (HCPs), elderly and those living with a medical risk condition. Although in Europe recommendations exist for annual influenza vaccination in these populations in most countries, the vaccination coverage rate (VCR) is often well below the World Health Organization target of 75% coverage. In our previous survey in 2009 we showed that some elements of national vaccination policies, e.g. reminder systems, strong official recommendation, and easy access, seemed to contribute to achieving higher influenza VCRs among elderly. We repeated the survey in 2016, using the same methodology to assess changes in influenza VCRs among the elderly and in the impact of policy elements on these VCRs. In addition, we collected information about VCRs among HCPs, and those living with a medical risk condition. The median VCR in the 21 countries that had recommendations for influenza vaccination in the elderly was 35.3%, ranging from 1.1% in Estonia to 74.5% in Scotland. The average VCRs for HCPs and those living with medical risk conditions, available in 17 and 10 countries, respectively, were 28.3% (range 7% in Czech Republic to 59.1% in Portugal) and 32.2% (range from 20.0% in the Czech Republic and Hungary to 59.6% in Portugal), respectively. Fewer countries were able to provide data from HCP and those living with medical risk conditions. Since the initial survey during the 2007-2008 influenza season, VCRs have decreased in the elderly in the majority of countries, thus, achieving high VCRs in the elderly and the other target groups is still a major public health challenge in Europe. This could be addressed by the identification, assessment and sharing of best practice for influenza vaccination policies.

• Klíčová slova
• Elderly, Seasonal influenza vaccination, Vaccination coverage, Vaccination policies, healthcare professionals, influenza, policy,
• MeSH
• chřipka lidská prevence a kontrola   MeSH
• kojenec MeSH
• lidé středního věku MeSH
• lidé MeSH
• očkovací programy organizace a řízení   statistika a číselné údaje   MeSH
• pokrytí očkováním statistika a číselné údaje   MeSH
• předškolní dítě MeSH
• roční období MeSH
• senioři MeSH
• těhotenství MeSH
• zdravotní politika * MeSH
• zdravotnické plány - realizace organizace a řízení   statistika a číselné údaje   MeSH
• Check Tag
• kojenec MeSH
• lidé středního věku MeSH
• lidé MeSH
• předškolní dítě MeSH
• senioři MeSH
• těhotenství MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• práce podpořená grantem MeSH
• Geografické názvy
• Evropa MeSH

AIM: To ensure that children are vaccinated, different national governments use diverse strategies. We compared childhood vaccination coverage rates between New York State (NYS) and New Zealand (NZ) as the vaccination strategies are different. METHODS: We used vaccination records from the NYS Immunisation Information System and the National Immunisation Register of NZ to measure (i) vaccination coverage by school entry and by age six; (ii) coverage of different socio-demographic groups; and (iii) trend in vaccination coverage between 2011 and 2015. RESULTS: We analysed the records of 583 767 NYS children and 269 800 NZ children 7 years of age. NZ children were 3.3-21.5% more likely than NYS children to receive each of the vaccines. Compared to NYS, NZ children were 39.6% more likely to be up-to-date by the start of school and 28.1% more likely to be up-to-date by age 6 years. Both NYS and NZ had statistically significant increases in the proportion of children who were up to date on each vaccine and all vaccines by the start of school and by 6 years of age (P < 0.001). CONCLUSIONS: We identified under-vaccinated groups and examined the point in the vaccine series where children were most vulnerable to being under-vaccinated. This information is useful in targeting future investigations and interventions aimed at mitigating disparities in vaccine coverage. This comparison of regions with different vaccination programmes and policies is important when considering whether the particular vaccination coverage strategies of one region could be adapted and applied for the benefit of another.

• MeSH
• dítě MeSH
• incidence MeSH
• kontrola infekčních nemocí metody   MeSH
• lidé MeSH
• městské obyvatelstvo MeSH
• očkovací schéma MeSH
• pokrytí očkováním statistika a číselné údaje   MeSH
• poliovirové vakcíny aplikace a dávkování   MeSH
• předškolní dítě MeSH
• vakcína proti diftérii, tetanu a pertusi aplikace a dávkování   MeSH
• vakcína proti hepatitidě B aplikace a dávkování   MeSH
• vakcína proti spalničkám, příušnicím a zarděnkám aplikace a dávkování   MeSH
• venkovské obyvatelstvo MeSH
• virové vakcíny MeSH
• Check Tag
• dítě MeSH
• lidé MeSH
• mužské pohlaví MeSH
• předškolní dítě MeSH
• ženské pohlaví MeSH
• Publikační typ
• časopisecké články MeSH
• srovnávací studie MeSH
• Geografické názvy
• New York MeSH
• Nový Zéland MeSH
• Názvy látek
• poliovirové vakcíny MeSH
• vakcína proti diftérii, tetanu a pertusi MeSH
• vakcína proti hepatitidě B MeSH
• vakcína proti spalničkám, příušnicím a zarděnkám MeSH
• virové vakcíny MeSH

INTRODUCTION: The Raise Awareness of Influenza Strategies in Europe (RAISE) group gathered information about the healthcare burden of influenza (hospitalizations, intensive care unit [ICU] admissions, and excess deaths), surveillance systems, and the vaccine coverage rate (VCR) in older adults in 18 European countries and Israel. AREAS COVERED: Published medical literature and official medical documentation on the influenza disease burden in the participating countries were reviewed from 2010/11 until the 2022/23 influenza seasons. Information on the framework for monitoring the disease burden and the provision for ensuring older adults had access to vaccination in their respective countries was provided. Data on influenza VCR in older adults were collected for the 2019/20 to 2022/23 influenza seasons. Data are reported descriptively. EXPERT OPINION: Influenza presents a significant healthcare burden in older adults. Reporting outcomes across participating countries is heterogeneous, highlighting the need for standardized approaches. Although older adults receive free influenza vaccination, vaccine uptake is highly variable among countries. Moreover, hospitalization rates remain high even in countries reporting a high VCR. Increased awareness and education on the burden of disease and the broader use of improved influenza vaccines for older adults may help reduce the disease burden on this population.

• Klíčová slova
• Influenza, Influenza surveillance, burden of disease, older adults, vaccine coverage rate,
• MeSH
• chřipka lidská * prevence a kontrola   epidemiologie   MeSH
• COVID-19 * prevence a kontrola   epidemiologie   MeSH
• hospitalizace * statistika a číselné údaje   MeSH
• lidé MeSH
• pokrytí očkováním * statistika a číselné údaje   MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• vakcíny proti chřipce * aplikace a dávkování   MeSH
• Check Tag
• lidé MeSH
• senioři nad 80 let MeSH
• senioři MeSH
• Publikační typ
• časopisecké články MeSH
• přehledy MeSH
• Geografické názvy
• Evropa epidemiologie   MeSH
• Izrael epidemiologie   MeSH
• Názvy látek
• vakcíny proti chřipce * MeSH

Plant traits-the morphological, anatomical, physiological, biochemical and phenological characteristics of plants-determine how plants respond to environmental factors, affect other trophic levels, and influence ecosystem properties and their benefits and detriments to people. Plant trait data thus represent the basis for a vast area of research spanning from evolutionary biology, community and functional ecology, to biodiversity conservation, ecosystem and landscape management, restoration, biogeography and earth system modelling. Since its foundation in 2007, the TRY database of plant traits has grown continuously. It now provides unprecedented data coverage under an open access data policy and is the main plant trait database used by the research community worldwide. Increasingly, the TRY database also supports new frontiers of trait-based plant research, including the identification of data gaps and the subsequent mobilization or measurement of new data. To support this development, in this article we evaluate the extent of the trait data compiled in TRY and analyse emerging patterns of data coverage and representativeness. Best species coverage is achieved for categorical traits-almost complete coverage for 'plant growth form'. However, most traits relevant for ecology and vegetation modelling are characterized by continuous intraspecific variation and trait-environmental relationships. These traits have to be measured on individual plants in their respective environment. Despite unprecedented data coverage, we observe a humbling lack of completeness and representativeness of these continuous traits in many aspects. We, therefore, conclude that reducing data gaps and biases in the TRY database remains a key challenge and requires a coordinated approach to data mobilization and trait measurements. This can only be achieved in collaboration with other initiatives.

• Klíčová slova
• TRY plant trait database, data coverage, data integration, data representativeness, functional diversity, plant traits,
• MeSH
• biodiverzita MeSH
• ekologie MeSH
• ekosystém * MeSH
• přístup k informacím * MeSH
• rostliny MeSH
• Publikační typ
• časopisecké články MeSH

AIM: To map the current seroprevalence of antibodies and vaccine coverage against viral hepatitis A (VHA) in the general population of the South Moravian Region (SMR). MATERIAL AND METHODS: During the VHA outbreak in 2016, nearly 3500 persons were investigated epidemiologically by the Regional Public Health Authority of the SMR within the anti-epidemic measures. The data collected were, among others, basic personal data and information whether the person has been vaccinated against VHA. For the reportedly vaccinated, the information was checked in the GP records or vaccination card. Those who reported to be unvaccinated were referred for serological testing. For the purposes of this retrospective prevalence study, available data on 3130 persons were analysed. The study population was divided into 10 age groups (0-4 years, 5-9 years, 10-14 years, 15-19 years, 20-24 years, 25-34 years, 35-44 years, 45-54 years, 55-65 years, and 65 years and over). The numbers of vaccinated persons with positive total antibodies and of those who tested negative were determined. The data obtained were statistically analysed using the Microsoft Excel tabular processor. RESULTS: Of the study cohort of 3130 persons, 659 (21.05 %) turned out to be seropositive, and 320 (10.22 %) of the seropositives were vaccinated. The seroprevalence rates in the age groups over 35 years were increasing with increasing age, being the highest (51.40 %) in those aged 65 years and older. The highest vaccine coverage rates were achieved in the age groups 10-14 years (20.73 %) and 15-19 years (20.77 %). CONCLUSION: The seroprevalence rates of antibodies against VHA in the general population of the SMR are very low (21.05 %), being even lower than previously reported. The vaccine coverage rate against VHA is 10.22 %. The results show higher vaccine coverage rates in those born after the vaccine against VHA was implemented. Children show the highest vaccine coverage rates. Adults tend to get vaccinated less often. This fact promotes the risk of infection spread and outbreaks, as recently evidenced by the spread of infection from persons engaging in risky behaviours to the general population of young working-age adults.

• Klíčová slova
• viral hepatitis A - seroprevalence - vaccine coverage rate - susceptibility.,
• MeSH
• dítě MeSH
• dospělí MeSH
• hepatitida A * epidemiologie   MeSH
• lidé MeSH
• retrospektivní studie MeSH
• senioři MeSH
• séroepidemiologické studie MeSH
• vakcinace statistika a číselné údaje   MeSH
• vakcíny * MeSH
• věkové faktory MeSH
• Check Tag
• dítě MeSH
• dospělí MeSH
• lidé MeSH
• senioři MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Česká republika epidemiologie   MeSH
• Názvy látek
• vakcíny * MeSH

In the evolving landscape of Industry 4.0, the integration of advanced wireless technologies into manufacturing processes holds the promise of unprecedented connectivity and efficiency. In particular, the data transmission in a heavy industry environment needs stable connectivity with mobile operators. This paper deals with the performance study of 4G and 5G mobile signal coverage within a complex factory environment. For this purpose, a cost-effective and portable measurement setup was realized and used to provide long-term measurement campaigns monitoring and recording several key parameter indicators (KPIs) in 4G/5G downlink and upload. To support the reproducibility of the provided study and other research activities, the measured dataset is publicly available for download. Among others findings, the obtained results show how the performance of 4G/5G is influenced by a heavy industry environment and of the time of day on the network load.

• Klíčová slova
• 4G, 5G, coverage mapping, industrial factory, key performance indicators, mobile networks,
• Publikační typ
• časopisecké články MeSH

The insufficient standardization of diagnostic next-generation sequencing (NGS) still limits its implementation in clinical practice, with the correct detection of mutations at low variant allele frequencies (VAF) facing particular challenges. We address here the standardization of sequencing coverage depth in order to minimize the probability of false positive and false negative results, the latter being underestimated in clinical NGS. There is currently no consensus on the minimum coverage depth, and so each laboratory has to set its own parameters. To assist laboratories with the determination of the minimum coverage parameters, we provide here a user-friendly coverage calculator. Using the sequencing error only, we recommend a minimum depth of coverage of 1,650 together with a threshold of at least 30 mutated reads for a targeted NGS mutation analysis of ≥3% VAF, based on the binomial probability distribution. Moreover, our calculator also allows adding assay-specific errors occurring during DNA processing and library preparation, thus calculating with an overall error of a specific NGS assay. The estimation of correct coverage depth is recommended as a starting point when assessing thresholds of NGS assay. Our study also points to the need for guidance regarding the minimum technical requirements, which based on our experience should include the limit of detection (LOD), overall NGS assay error, input, source and quality of DNA, coverage depth, number of variant supporting reads, and total number of target reads covering variant region. Further studies are needed to define the minimum technical requirements and its reporting in diagnostic NGS.

• Klíčová slova
• TP53 gene, coverage depth calculator, next-generation sequencing, sequencing error, small subclones, variant allele frequency (VAF),
• Publikační typ
• časopisecké články MeSH

• Klíčová slova
• COVID-19, Influenza vaccination, SARS-CoV-2, coverage rates, influenza,
• MeSH
• chřipka lidská * epidemiologie   prevence a kontrola   MeSH
• COVID-19 * MeSH
• lidé MeSH
• pandemie prevence a kontrola   MeSH
• pokrytí očkováním MeSH
• roční období MeSH
• SARS-CoV-2 MeSH
• vakcinace MeSH
• vakcíny proti chřipce * MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Austrálie epidemiologie   MeSH
• Názvy látek
• vakcíny proti chřipce * MeSH

Employers that must provide medical benefits for employees in Russia and other Eastern European countries cannot try to match the coverage they provide in the United States. This article, which focuses on the Czech Republic, Hungary, Poland and Russia, summarizes the medical benefits provided by each government's social security system, describes other means of accessing medical care in these countries and outlines the insured supplemental benefit plans that may be available to employers in the local market.

• MeSH
• daně MeSH
• kulturní charakteristiky MeSH
• lidé MeSH
• nemocenské dávky pracujícím - plány ekonomika   organizace a řízení   normy   MeSH
• pojistné krytí * MeSH
• postoj MeSH
• státní lékařství MeSH
• zajištění kvality zdravotní péče MeSH
• Check Tag
• lidé MeSH
• Publikační typ
• časopisecké články MeSH
• Geografické názvy
• Česká republika MeSH
• Maďarsko MeSH
• Polsko MeSH
• Rusko MeSH